Direct Impacts

Baxter's direct impacts are described by payments Baxter makes to and receives from various stakeholder groups during the course of business. For example:

The following table summarizes these transactions.

ECONOMIC VALUE GENERATED AND DISTRIBUTED (DOLLARS IN MILLIONS)
2004 2005 2006 2007 2008
Economic Value Generated
Revenues $9,509 $9,849 $10,378 $11,263 $12,348
Net Income 388 956 1,397 1,707 2,014
Economic Value Distributed
Suppliers
Payments to Suppliers (approximate) n/a $4,000 $4,100 $4,100 $4,400
Investors
Share Repurchases 18 0 737 1,855 1,986
Common Stock Cash Dividends 361 359 364 704 546
Governments
Income Tax Expense ( U.S.) (102) 232 30 228 205
Income Tax Expense (international) 149 254 318 179 232
Communities
Cash Donations1 7.2 17.6 20.7 23.5 28.9
Product Donations 7.9 17.8 14.9 31.1 10.9
Baxter (Reinvested)
Capital Expenditures 558 444 526 692 954
R&D Expenses 517 533 614 760 868

1 Baxter and The Baxter International Foundation.

BAXTER SHARE PERFORMANCE

The following graph compares the change in Baxter’s cumulative total shareholder return on its common stock with the Standard & Poor’s 500 Composite Index and the Standard & Poor’s 500 Health Care Index as of December 31 of each year.

For additional detail, see Baxter’s interactive stock chart.

Local communities may benefit from Baxter’s presence in addition to the wages the company pays employees, such as when Baxter makes infrastructure investments with benefits beyond the company. In some Baxter plants, such as in Baxter’s Cuernavaca, Mexico, facility, Baxter supports physicians employed by the plant to provide free or inexpensive healthcare to employees’ families and community members. In 2008, the Cuernavaca plant as well as Baxter plants in Aibonito, Puerto Rico; Miyazaki, Japan; and Mountain Home, Arkansas, United States, provided flu vaccinations to employee family members at no charge.

In addition, many Baxter facilities support local charities (see Critical Community Needs for detail).